Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 759.33B | 741.39B | 764.70B | 739.26B | 608.33B | 492.62B |
Gross Profit | 260.55B | 223.94B | 188.75B | 228.32B | 203.05B | 168.84B |
EBITDA | 130.03B | 99.74B | 54.13B | 112.73B | 104.95B | 78.39B |
Net Income | 72.90B | 43.69B | 11.71B | 64.77B | 62.02B | 47.73B |
Balance Sheet | ||||||
Total Assets | 1.10T | 1.06T | 1.10T | 1.01T | 812.88B | 674.56B |
Cash, Cash Equivalents and Short-Term Investments | 262.23B | 215.21B | 162.72B | 71.06B | 148.64B | 143.44B |
Total Debt | 11.27B | 19.89B | 203.62B | 96.46B | 16.45B | 19.74B |
Total Liabilities | 173.81B | 180.60B | 323.65B | 254.97B | 149.55B | 98.82B |
Stockholders Equity | 923.77B | 868.16B | 769.25B | 746.34B | 657.86B | 571.27B |
Cash Flow | ||||||
Free Cash Flow | 139.79B | 219.24B | 5.34B | -163.60B | 14.68B | 12.90B |
Operating Cash Flow | 157.15B | 237.09B | 44.43B | -103.66B | 64.54B | 57.31B |
Investing Cash Flow | -18.93B | -25.62B | -37.68B | -27.89B | -42.91B | -30.51B |
Financing Cash Flow | -37.04B | -191.28B | 80.97B | 52.63B | -23.04B | -22.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $11.68B | 25.83 | 34.83% | 1.42% | -2.29% | -14.49% | |
74 Outperform | $16.26B | 16.28 | 19.15% | 2.77% | -0.88% | 0.04% | |
74 Outperform | $5.12B | 15.80 | 11.85% | 1.89% | -3.69% | -11.76% | |
71 Outperform | $8.12B | 15.44 | 8.74% | 2.66% | -3.70% | 72.77% | |
68 Neutral | $10.25B | 28.14 | 4.03% | 4.85% | -3.04% | ― | |
67 Neutral | €8.43B | 18.51 | 6.19% | 2.70% | 2.33% | -39.06% | |
64 Neutral | $6.94B | 18.02 | 25.50% | 2.14% | 2.98% | 54.13% |